STATUTORY RULES.
1954. No. 93
REGULATIONS UNDER THE NATIONAL HEALTH ACT 1953.*
I, THE GOVERNOR-GENERAL in and over the Commonwealth of Australia, acting with the advice of the Federal Executive Council, hereby make the following Regulations under the National Health Act 1953.
Dated this eighteenth
day of August , 1954.
W. J. Slim
Governor-General.
By His Excellency’s Command,
Minister of State for Health.
Amendments of the National Health (Pharmaceutical Benefits) Regulations.†
Interpretation.
1. Regulation 2 of the National Health (Pharmaceutical Benefits) Regulations is amended—
(a) by inserting in sub-regulation (1.), after the definition of
“authorized prescription form”, the following definition:—
“‘brand’ means a brand of a pharmaceutical benefit in respect of which the Minister has determined a rate of payment;”;
* Notified in the Commonwealth Gazette on , 1954
† Statutory Rules 1954, No. 54, as amended by Statutory Rules 1954, Nos. 77
3037.—Price 1s. 6d. 10/3.8.1954.
(b) by omitting from paragraph (a) of sub-regulation (2.) the word “and” (last occurring); and
(c) by omitting paragraph (b) of sub-regulation (2.).
General pharmaceutical benefits.
2. Regulation 8 of the National Health (Pharmaceutical Benefits) Regulations is amended by omitting sub-regulation (4.) and inserting in its stead the following sub-regulation:—
“(4.) Water for Injection as prescribed in the First Schedule is not a general pharmaceutical benefit unless it is prescribed for supply in conjunction with and for administration with—
(a) a drug or medicinal preparation that is prescribed as a general pharmaceutical benefit in the form of a hypodermic tablet; or
(b) one of the following drugs or medicinal preparations as prescribed as general pharmaceutical benefits:—
Aureomycin.
Dihydrostreptomycin.
Hyalase.
Injection of Neoarsphenamine.
Penethamate Hydriodide.
Injection of Penicillin.
Injection of Phenobarbitone Sodium.
Injection of Procaine Penicillin (Crystalline).
Rondase.
Streptomycin.
Terramycin.
Tetracycline.
Wydase.”.
Exceptions to pensioner benefits in British Pharmacopoeia.
3. Regulation 9 of the National Health (Pharmaceutical Benefits) Regulations is amended by omitting paragraph (b) of sub-regulation (1.).
Writing of prescriptions.
4. Regulation 19 of the National Health (Pharmaceutical Benefits) Regulations is amended by omitting from paragraph (e) of sub-regulation (1.) the words “by the trade name of a manufacturer an abbreviation of whose name appears in the column headed ‘Brand’ in that Schedule” and inserting in their stead the words “by a brand of that benefit”.
First, Second and Third Schedules.
5. The First, Second and Third Schedules to National Health (Pharmaceutical Benefits) Regulations are repealed and the following Schedules inserted in their stead:—
FIRST SCHEDULE. Reg. 8.
Drugs and Medicinal Preparations that may be Prescribed for Supply, Supplied and Received as General Pharmaceutical Benefits.
Item Number. | Name or Formula. | Strength. | Form of Unit. | Maximum Quantity or Number of Units. | Number of Repeats. |
1 | Acetarsol Soluble, Injection of .......... | .......................... | 2 cc. amp.................... | 10 | 1 |
|
| .......................... | 3 cc. amp.................... | 10 | 1 |
2 | Adrenalin Hydrochloride, Solution of | 1 in 1,000 ................... | 0.5 cc. amp................... | 6 | 1 |
| 1 in 1,000 ................... | 1 cc. amp.................... | 6 | 1 | |
|
| 1 in 1,000 ................... | 10 cc. vial ................... | 1 | 1 |
|
| 1 in 1,000 ................... | 1 fl. oz. bottle ................. | 1 | .. |
|
| 1 in 1,000 ................... | 1 fl. oz. vial .................. | 1 | .. |
|
| 1 in 100 ..................... | 6 cc. vial .................... | 1 | .. |
|
| 1 in 100 ..................... | 10 cc. vial ................... | 1 |
|
3 | Adrenalin in Oil, Injection of ........... | 2 mg. per cc................... | 1 cc. amp.................... | 6 | 1 |
4 | Adrenalin Tartrate, Solution of .......... | 1 in 1,000 ................... | 1 cc. amp.................... | 6 | 1 |
|
| 1 in 1,000 ................... | 10 cc. amp.................... | 1 | 1 |
|
| 1 in 1,000 ................... | 25 cc. bottle .................. | 1 | .. |
|
| 1 in 1,000 ................... | 30 cc. vial ................... | 1 | .. |
|
| 1 in 1,000 ................... | 1 fl. oz. bottle ................. | 1 | .. |
|
| 1 in 100 ..................... | 7 cc. vial .................... | 1 | .. |
5 | Aloxidone ........................ | 0.3 G....................... | capsule ..................... | 100 | 1 |
6 | Amidone ......................... | 5 mg. per cc................... | 2 cc. amp.................... | 6 | .. |
|
| 5 mg. per cc................... | 10 cc. vial ................... | 1 | .. |
|
| 10 mg. per cc.................. | 1 cc. amp.................... | 6 | .. |
|
| 10 mg. per cc.................. | 10 cc. vial ................... | 1 | .. |
|
| 10 mg. per cc.................. | 20 cc. vial ................... | 1 | .. |
|
| 2.5 mg. ..................... | tablet ...................... | 25 | .. |
|
| 5 mg. ...................... | tablet ...................... | 25 | .. |
|
| 7.5 mg. ..................... | tablet ...................... | 25 | .. |
|
| 10 mg....................... | tablet ...................... | 25 | .. |
First Schedule—continued.
Item Number. | Name or Formula. | Strength. | Form of Unit. | Maximum Quantity or Number of Units. | Number of Repeats. |
7 | Amyl Nitrite ....................... | 2 min....................... | capsule ...................... | 12 | 1 |
|
| 3 min....................... | capsule ...................... | 12 | 1 |
|
| 4 min....................... | capsule ...................... | 12 | 1 |
|
| 5 min. ..................... | capsule ...................... | 12 | 1 |
8 | Anahaemin ....................... | .......................... | 2 cc. amp..................... | 12 | 1 |
9 | Anahepol ......................... | .......................... | 2 cc. amp..................... | 12 | 1 |
10 | Antazoline, Injection of ............... | 0.1 G. per 2 cc................. | 2 cc. amp..................... | 10 | .. |
11 | Atropine Sulphate ................... | 1/150 gr. per cc................ | 1 cc. amp..................... | 6 | 1 |
|
| 1/100 gr. per cc ............... | 1 cc. amp. .................... | 6 | 1 |
|
| 1/100 gr. per cc ............... | 10 cc. vial .................... | 1 | .. |
|
| 1/50 gr. Per cc ................ | 1 cc. amp. .................... | 6 | 1 |
|
| 1/100 gr. .................... | hypo. tab. | 20 | 1 |
|
| 1/150 gr..................... | hypo. tab. .................... | 20 | 1 |
|
| 1/100 gr. .................... | hypo. tab. .................... | 20 | 1 |
12 | Aurothioglucose, Oily Injection of | 0.01 G. ..................... | amp......................... | 1 | 3 |
|
| 0.025 G. .................... | amp......................... | 1 | 3 |
|
| 0.05 G...................... | amp......................... | 6 | .. |
|
| 0.1 G....................... | amp......................... | 6 | .. |
|
| 0.01 G. per cc................. | 10 cc. vial .................... | 1 | .. |
|
| 0.1 G. per cc.................. | 10 cc. vial .................... | 1 | .. |
13 | Benzhexol Hydrochloride .............. | 2 mg....................... | tablet ....................... | 100 | 1 |
|
| 5 mg....................... | tablet ....................... | 100 | 1 |
14 | Bismuth, Aqueous Injection of | .......................... | 5 cc. amp..................... | 2 | .. |
|
| .......................... | 10 cc. amp.................... | 1 | .. |
|
| .......................... | 25 cc. bottle .................. | 1 | .. |
|
| .......................... | 1 fl. oz. bottle ................. | 1 | .. |
First Schedule—continued.
Item Number. | Name or Formula. | Strength. | Form of Unit. | Maximum Quantity or Number of Units. | Number of Repeats. |
15 | Bismuth Oxychloride, Aqueous Injection of | .......................... | 1 cc. amp..................... | 12 | .. |
| .......................... | 2 cc. amp..................... | 12 | .. | |
|
| .......................... | 3 cc. amp..................... | 12 | .. |
|
| .......................... | 25 cc. bottle .................. | 1 | .. |
|
| .......................... | 30 cc. bottle .................. | 1 | .. |
16 | Bismuth Oxychloride, Oily Injection of | .......................... | 2 cc. amp..................... | 12 | .. |
| .......................... | 3 cc. amp..................... | 12 | .. | |
17 | Bismuth Salicylate, Oily Injection of | .......................... | 1 cc. amp..................... | 12 | .. |
| .......................... | 10 cc. amp.................... | 6 | .. | |
|
| .......................... | 25 cc. bottle.................. | 1 | .. |
|
| .......................... | 50 cc. bottle.................. | 1 | .. |
|
| .......................... | 60 cc. bottle.................. | 1 | .. |
|
| .......................... | 2 fl. oz. bottle................. | 1 | .. |
18 | Calcium Aurothiomalate, Injection of | 10 mg....................... | amp........................ | 1 | 3 |
| 25 mg....................... | amp........................ | 1 | 3 | |
|
| 50 mg....................... | amp........................ | 6 | .. |
|
| 100 mg...................... | amp........................ | 6 | .. |
19 | Calf Lymph.................. | .......................... | capillary tube ................. | 1 | .. |
20 | Camoquin Hydrochloride......... | 0.2 G....................... | tablet ...................... | 25 | .. |
21 | Campolon................... | .......................... | 2 cc. amp..................... | 6 | 1 |
|
| .......................... | 5 cc. amp..................... | 6 | 1 |
|
| .......................... | 10 cc. vial ................... | 1 | 1 |
22 | Campolon Forte............... | .......................... | 1 cc. amp..................... | 6 | 1 |
|
| .......................... | 5 cc. vial .................... | 1 | 1 |
|
| .......................... | 10 cc. vial ................... | 1 | 1 |
First Schedule—continued.
Item Number. | Name or Formula. | Strength. | Form of Unit. | Maximum Quantity or Number of Units. | Number of Repeats. |
23 | Carbachol......................... | 0.25 mg. per cc................. | 1 cc. amp..................... | 6 | .. |
|
| 2 mg........................ | tablet....................... | 25 | 3 |
24 | Carbarsone........................ | 0.25 G...................... | capsule..................... | 20 | 1 |
|
| 0.25 G...................... | tablet....................... | 20 | 1 |
25 | Casydrol.......................... | 2½%....................... | 500 cc. bottle................. | 1 | .. |
|
| 5%........................ | 500 cc. bottle................. | 1 | .. |
26 | Chiniofon......................... | 0.25 G...................... | pill........................ | 25 | 1 |
|
| 0.25 G...................... | tablet....................... | 25 | 1 |
|
| 0.5 G....................... | tablet....................... | 25 | 1 |
27 | Chloroquine....................... | 0.2 G....................... | tablet....................... | 100 | 1 |
|
| 250 mg...................... | tablet....................... | 100 | 1 |
28 | Cholera Vaccine..................... | 4,000 M. per cc................ | 1 cc. amp..................... | 3 | .. |
|
| 4,000 M. per cc................ | 10 cc. vial.................... | 1 | .. |
|
| 8,000 M. per cc................ | 1 cc. amp..................... | 2 | .. |
|
| 8,000 M. per cc................ | 10 cc vial.................... | 1 | .. |
29 | Dapsone.......................... | 50 mg....................... | tablet ...................... | 100 | .. |
|
| 100 mg...................... | tablet ...................... | 100 | .. |
30 | Darrow’s Solution................... | .......................... | 1 litre bottle .................. | 2 | 1 |
31 | Dextrose, Aqueous Injection of........... | 5%........................ | 1 litre bottle .................. | 6 | 1 |
|
| 10%....................... | 1 litre bottle .................. | 2 | 1 |
|
| 20%....................... | 1 litre bottle .................. | 2 | 1 |
|
| 25%....................... | 1 litre bottle .................. | 2 | 1 |
|
| 50%....................... | 25 cc. amp.................... | 6 | 1 |
|
| 60%....................... | 50 cc. amp.................... | 6 | 1 |
First Schedule—continued.
Item Number. | Name or Formula. | Strength. | Form of Unit. | Maximum Quantity | Number of Repeats. |
32 | Dextrose in ⅕ Normal Saline for Injection | 4%........................ | 1 litre bottle................... | 6 | 1 |
33 | Dextrose in Ringer’s Solution for | 5%........................ | 1 litre bottle................... | 6 | 1 |
| Injection | 10%....................... | 1 litre bottle................... | 3 | 1 |
34 | Diasone.......................... | 0.33 G...................... | tablet....................... | 200 | 1 |
35 | Dicoumarol........................ | 100 mg...................... | amp........................ | 3 |
|
|
| 50 mg....................... | capsule...................... | 50 | 1 |
|
| 100 mg...................... | capsule...................... | 50 | 1 |
|
| 50 mg....................... | tablet....................... | 50 | 1 |
36 | Diethazine Hydrochloride.............. | 0.05 G...................... | tablet....................... | 100 | 1 |
|
| 0.25 G...................... | tablet....................... | 100 | 1 |
37 | Diethylcarbamazine.................. | 50 mg....................... | tablet....................... | 20 | 1 |
38 | Digifortis......................... | ½ gr....................... | tablet....................... | 50 | 1 |
|
| 1 gr........................ | tablet....................... | 50 | 1 |
39 | Digitalis.......................... | ½ gr....................... | tablet....................... | 100 | 1 |
|
| 1 gr........................ | tablet....................... | 100 | 1 |
40 | Digitoxin | 1/100 gr..................... | hypo. tab..................... | 20 | 1 |
|
| 0.1 mg...................... | tablet....................... | 100 | 1 |
|
| 0.2 mg...................... | tablet....................... | 100 | 1 |
|
| 0.25 mg..................... | tablet....................... | 100 | 1 |
41 | Digoxin.......................... | 0.5 mg. per cc................. | 1 cc. amp..................... | 12 | 1 |
|
| 0.5 mg. per cc................. | 30 cc. bottle................... | 1 | 1 |
|
| 0.25 mg..................... | tablet....................... | 100 | 1 |
First Schedule—continued.
Item Number. | Name or Formula. | Strength. | Form of Unit. | Maximum Quantity | Number of Repeats. |
42 | Dihydroergotamine, Injection of .......... | 1 mg. per cc................... | 1 cc. amp.................... | 6 | .. |
43 | Dihydromorphinone.................. | .......................... | 1.1 cc. amp................... | 4 | .. |
|
| 1/32 gr................... | hypo. tab..................... | 20 | .. |
|
| 1/20 gr...................... | hypo. tab..................... | 20 | .. |
|
| 1/26 gr...................... | tablet....................... | 20 | .. |
44 | Diiodohydroxyquinoline................ | 0.21 G...................... | tablet....................... | 100 | 1 |
|
| 0.3 G....................... | tablet....................... | 100 | 1 |
45 | Dimercaprol, Injection of............... | .......................... | 2 cc. amp.................... | 12 |
|
46 | Diphenhydramine Hydrochloride, Injection of | 10 mg. per cc. ................ | 10 cc. vial................... | 1 | 1 |
47 | Diphtheria and Tetanus Toxoids Combined | .......................... | 1 cc. amp.................... | 3 | .. |
| .......................... | 5 cc. amp.................... | 1 | .. | |
48 | Diphtheria Antitoxin.................. | 1,000 U..................... | amp........................ | 2 | 1 |
|
| 2,000 U..................... | amp........................ | 2 | 1 |
|
| 4,000 U..................... | amp........................ | 2 | 1 |
|
| 6,000 U..................... | amp........................ | 2 | 1 |
|
| 8,000 U..................... | amp........................ | 2 | 1 |
|
| 10,000 U..................... | amp........................ | 2 | 1 |
|
| 20,000 U..................... | amp........................ | 2 | 1 |
49 | Diphtheria Pertussis Antigen............. | .......................... | 1 cc. amp.................... | 3 | .. |
|
| .......................... | 5 cc. amp.................... | 1 | .. |
|
| .......................... | 5 cc. vial.................... | 1 | .. |
|
| .......................... | 7.5 cc. vial................... | 1 | .. |
|
| .......................... | 10 cc. vial ................... | 1 | .. |
First Schedule—continued.
Item Number. | Name or Formula. | Strength. | Form of Unit. | Maximum Quantity or Number of Units. | Number of Repeats. |
50 | Diphtheria, Pertussis and Tetanus Antigen | .......................... | 1 cc. amp..................... | 3 | .. |
| .......................... | 5 cc. amp..................... | 1 | .. | |
|
| .......................... | 7.5 cc. vial................... | 1 | .. |
|
| .......................... | 10 cc. vial................... | 1 | .. |
51 | Diphtheria Prophylactic (Formalinized Toxoid) | .......................... | set containing 3 amps. each 1 cc. Toxoid undiluted and 1 amp. of 1 cc. Toxoid diluted | 1 | 1 |
|
| .......................... | set containing 9 amps. each 1 cc. Toxoid undiluted and 3 amps. of 1 cc. Toxoid diluted | 1 | .. |
52 | Diphtheria Prophylactic (Purified Toxoid Aluminium Phosphate) | .......................... | 1 cc. amp..................... | 2 | 1 |
| .......................... | 5 cc. vial.................... | 1 | .. | |
|
| .......................... | 10 cc. vial................... | 1 | .. |
|
| .......................... | set containing 2 amps. each 1 cc. Toxoid for use in adults and 1 amp. of 1 cc. Toxoid diluted for skin test | 1 | .. |
53 | Diphtheria Toxoid Purified (Diluted for skin test only) | .......................... | 1 cc. amp..................... | 1 | .. |
54 | Emetine Hydrochloride................ | 20 mg. per cc.................. | 1 cc. amp..................... | 12 | .. |
|
| 30 mg. per cc.................. | 1 cc. amp..................... | 12 | .. |
|
| 65 mg. per cc.................. | 1 cc. amp..................... | 6 | .. |
|
| ½ gr....................... | tablet....................... | 12 | .. |
55 | Emetine Bismuth Iodide............... | 1 gr....................... | tablet....................... | 25 | 1 |
|
| 2 gr....................... | tablet....................... | 25 | 1 |
56 | Entero-vioform..................... | 0.25 G...................... | tablet....................... | 100 | 1 |
First Schedule—continued.
Item Number. | Name or Formula. | Strength. | Form of Unit. | Maximum Quantity or Number of Units. | Number of Repeats. |
57 | Ephedrine Hydrochloride............... | ½ gr. per cc................... | 1 cc. amp..................... | 6 | 1 |
|
| ¾ gr. per cc................... | 1 cc. amp..................... | 6 | 1 |
|
| ½ gr........................ | hypo. tab..................... | 20 | 1 |
|
| ¼ gr........................ | tablet ...................... | 100 | 1 |
|
| ½ gr........................ | tablet ...................... | 100 | 1 |
|
| 1 gr........................ | tablet ...................... | 100 | 1 |
58 | Ephedrine Sulphate................... | ½ gr. per cc................... | 1 cc. amp..................... | 6 | 1 |
|
| 5%........................ | 1 cc. amp..................... | 6 | 1 |
|
| 3/8 gr....................... | capsule..................... | 40 | 1 |
|
| ¾ gr........................ | capsule..................... | 40 | 1 |
|
| ½ gr........................ | hypo. tab..................... | 20 | 1 |
|
| ¼ gr........................ | tablet....................... | 100 | 1 |
|
| ½ gr........................ | tablet....................... | 100 | 1 |
59 | Ergometrine Maleate.................. | 0.2 mg. per cc.................. | 1 cc. amp..................... | 6 | .. |
|
| 0.5 mg. per cc.................. | 1 cc. I.M. amp................. | 6 | .. |
|
| 0.125 mg. per cc................ | 1 cc. I.V. amp.................. | 6 | .. |
|
| 0.2 mg....................... | tablet ...................... | 25 | .. |
|
| 0.5 mg....................... | tablet....................... | 25 | .. |
60 | Ergot (Prepared)..................... | ........................... | 1 cc. amp..................... | 6 | .. |
|
| 2½ gr....................... | capsule..................... | 25 | 1 |
|
| 2½ gr....................... | tablet....................... | 25 | 1 |
|
| 4 gr........................ | tablet....................... | 25 | 1 |
61 | Ergotamine Tartrate.................. | ........................... | 0.5 cc. amp................... | 6 | .. |
|
| ........................... | 1 cc. amp..................... | 6 | .. |
|
| 1 mg........................ | tablet....................... | 15 | 1 |
62 | ergotoxine Ethanesulphonate............. | 0.5 mg....................... | tablet....................... | 25 | .. |
63 | Ethopropazine Hydrochloride............ | 50 mg....................... | tablet....................... | 100 | 1 |
First Schedule—continued.
Item Number. | Name or Formula. | Strength. | Form of Unit. | Maximum Quantity | Number of Repeats. |
64 | Ethyl Biscoumacetate.................. | 300 mg...................... | tablet....................... | 100 | .. |
65 | Ethylidene Dicoumarin................. | 100 mg...................... | tablet....................... | 50 | 1 |
66 | Examen........................... | ........................... | 1 cc. amp..................... | 12 | 1 |
|
| ........................... | 5 cc. amp..................... | 1 | 1 |
67 | Exatrope.......................... | ........................... | 2 cc. amp..................... | 12 | 1 |
|
| ........................... | 12 cc. amp.................... | 1 | 1 |
68 | Gas Gangrene Antitoxin (Oedematiens) | 10,000 U..................... | amp........................ | 3 | 1 |
69 | Gas Gangrene Antitoxin (Perfringens) | 4,000 U...................... | amp........................ | 3 | 1 |
|
| 10,000 U..................... | amp........................ | 10 | 1 |
70 | Gas Gangrene Antitoxin (Polyvalent) | 3,000 U. perfringens |
|
|
|
|
| 1,500 U. septique | 1 amp....................... | 2 | 1 |
|
| 1,000 U. oedematiens |
|
|
|
|
| 7,500 U. perfringens |
|
|
|
|
| 3,750 U. septique | 1 amp....................... | 2 | 1 |
|
| 2,500 U. oedematiens |
|
|
|
71 | Gas Gangrene Antitoxin (Septique)......... | 5,000 U...................... | amp........................ | 2 | 1 |
72 | Glyceryl Trinitrate.................... | 1/100 gr...................... | hypo. tab..................... | 50 | 1 |
|
| 1/200 gr...................... | tablet ...................... | 50 | 1 |
|
| 1/150 gr...................... | tablet ...................... | 50 | 1 |
|
| 1/130 gr...................... | tablet ...................... | 50 | 1 |
|
| 1/100 gr...................... | tablet ...................... | 50 | 1 |
|
| 1/65 gr....................... | tablet ...................... | 50 | 1 |
|
| 1/50 gr....................... | tablet ...................... | 50 | 1 |
73 | Hartmann’s Solution.................. | ........................... | 1 litre bottle .................. | 2 | 1 |
First Schedule—continued.
Item Number. | Name or Formula. | Strength. | Form of Unit. | Maximum Quantity or Number of Units. | Number of Repeats. |
74 | Hartmann’s Solution with Dextrose | 50%....................... | 1 litre bottle.................. | 2 | 1 |
|
| 10%....................... | 1 litre bottle.................. | 2 | 1 |
75 | Heparin, Injection of.................. | 1,000 U. per cc................. | 5 cc. vial.................... | 5 | .. |
|
| 1,000 U. per cc................. | 10 cc. vial.................... | 1 | .. |
|
| 5,000 U. per cc................. | 5 cc. vial.................... | 1 | .. |
|
| 25,000 U. per cc................ | 5 cc. vial.................... | 1 | .. |
76 | Heparin Retard, Injection of............. | 20,000 U. per 2 mil.............. | 2 mil. amp.................... | 6 | .. |
77 | Hepastab.......................... | ........................... | 2 cc. amp..................... | 6 | 1 |
|
| ........................... | 10 cc. vial.................... | 1 | 1 |
78 | Hepastab Forte...................... | ........................... | 1 cc. amp..................... | 6 | 1 |
|
| ........................... | 2 cc. amp..................... | 3 | 1 |
|
| ........................... | 10 cc. vial.................... | 1 | 1 |
79 | Hepatex-T......................... | ........................... | 2 cc. amp..................... | 12 | 1 |
|
| ........................... | 10 cc. vial.................... | 1 | 1 |
80 | Hepolon.......................... | ........................... | 2 cc. amp..................... | 12 | 1 |
|
| ........................... | 10 cc. vial ................... | 1 | 1 |
81 | Hyalase........................... | 1 mg........................ | amp........................ | 5 | 1 |
82 | Hyoscine Hydrobromide............... | 1/150 gr...................... | amp........................ | 6 | .. |
|
| 1/100 gr...................... | amp........................ | 6 | .. |
|
| 1/75 gr...................... | amp........................ | 6 | .. |
|
| 1/200 gr...................... | hypo. tab..................... | 100 | 1 |
|
| 1/150 gr...................... | hypo. tab..................... | 100 | 1 |
|
| 1/100 gr...................... | hypo. tab..................... | 100 | 1 |
|
| 1/50 gr...................... | hypo. tab..................... | 100 | 1 |
|
| 1/150 gr. per cc................. | 10 cc. vial.................... | 1 |
|
First Schedule—continued.
Item Number. | Name or Formula. | Strength. | Form of Unit. | Maximum Quantity | Number of Repeats. |
83 | Insulin, Injection of................... | 20 U. per cc................... | 5 cc. vial..................... | 3 | 12 |
|
| 20 U. per cc................... | 10 cc. vial.................... | 3 | 12 |
|
| 40 U. per cc................... | 5 cc. vial..................... | 3 | 12 |
|
| 40 U. per cc................... | 10 cc. vial.................... | 3 | 12 |
|
| 60 U. per cc................... | 5 cc. vial..................... | 3 | 12 |
|
| 80 U. per cc. .................. | 5 cc. vial..................... | 3 | 12 |
|
| 80 U. per cc. .................. | 10 cc. vial.................... | 3 | 12 |
|
| 100 U. per cc................... | 5 cc. vial..................... | 3 | 12 |
84 | Insulin (Crystalline), Injection of.......... | 40 U. per cc................... | 10 cc. vial.................... | 3 | 12 |
85 | Insulin Globin Zinc, Injection of........... | 40 U. per cc................... | 5 cc. vial..................... | 3 | 12 |
|
| 80 U. per cc................... | 5 cc. vial..................... | 3 | 12 |
86 | Insulin, Isophane, Injection of............ | 40 U. per cc................... | 5 cc. vial..................... | 3 | 12 |
|
| 40 U. per cc................... | 10 cc. vial.................... | 3 | 12 |
|
| 80 U. per cc................... | 10 cc. vial.................... | 3 | 12 |
87 | Insulin (Special P), Injection of........... | 20 U. per cc................... | 10 cc. vial.................... | 3 | 12 |
|
| 40 U. per cc................... | 10 cc. vial.................... | 3 | 12 |
|
| 60 U. per cc................... | 5 cc. vial..................... | 3 | 12 |
88 | Insulin Protamine Zinc, Injection of | 40 U. per cc................... | 5 cc. vial..................... | 3 | 12 |
|
| 40 U. per cc................... | 10 cc. vial.................... | 3 | 12 |
|
| 80 U. per cc................... | 5 cc. vial..................... | 3 | 12 |
|
| 80 U. per cc................... | 10 cc. vial.................... | 3 | 12 |
89 | Isoprenaline Hydrochloride.............. | 1 in 200 ..................... | ½ fl. oz. bottle................. | 1 | 1 |
|
| 10 mg....................... | tablet....................... | 25 | 3 |
90 | Isoprenaline Sulphate.................. | 20 mg....................... | tablet....................... | 25 | 3 |
|
| 10 mg. per cc.................. | 7 cc. vial..................... | 1 | 1 |
|
| ........................... | 10 cc. vial.................... | 1 | .. |
First Schedule—continued.
Item Number. | Name or Formula. | Strength. | Form of Unit. | Maximum Quantity or Number of Units. | Number of Repeats. |
91 | Kinaden.......................... | 10 U. per amp.................. | set containing 3 amps. and 3 amps of solvent | 1 | 1 |
92 | Lanatoside C....................... | 0.2 mg. per cc.................. | 2 cc. amp..................... | 6 | 1 |
|
| 0.25 mg...................... | tablet....................... | 40 | 1 |
93 | Leptazol, Injection of................. | ........................... | 1 cc. amp..................... | 6 | .. |
|
| ........................... | 1.1 cc. amp.................... | 6 | .. |
|
| ........................... | 3 cc. amp..................... | 2 | .. |
|
| ........................... | 5 cc. amp..................... | 1 | .. |
94 | Livadex.......................... | ........................... | 2 cc. amp..................... | 12 | 1 |
95 | Liver Extract, Injection of.............. | 2 U.S.P. U. per cc............... | 1 cc. amp..................... | 6 | 1 |
|
| 2 U.S.P. U. per cc............... | 10 cc. vial.................... | 6 | 1 |
|
| 5 U.S.P. U. per cc............... | 2 cc. vial..................... | 6 | 1 |
|
| 5 U.S.P. U. per cc............... | 10 cc. vial.................... | 1 | 1 |
|
| 5 U.S.P. U. per cc............... | 20 cc. vial.................... | 1 | 1 |
|
| 10 U.S.P. U. per cc.............. | 10 cc. vial.................... | 1 | 1 |
|
| 15 U.S.P. U. per cc.............. | 5 cc. vial..................... | 1 | 1 |
96 | Mepacrine Hydrochloride............... | 0.1 G........................ | tablet....................... | 100 | 1 |
97 | Mepacrine Methanesulphonate, Injection of | 0.12 G....................... | amp........................ | 6 | 1 |
|
| 0.36 G....................... | amp........................ | 6 | 1 |
98 | Meprochol, Injection of................ | 3 mg. per cc................... | 1 cc. amp..................... | 6 | .. |
99 | Mepyramine Maleate, Injection of......... | 2.5%....................... | 2 cc. amp..................... | 10 | .. |
100 | Mercaptomerin Sodium................ | 1.4 G. per vial................. | set containing one vial and 10 cc. Water for Injection | 3 | .. |
First Schedule—continued.
Item Number. | Name or Formula. | Strength. | Form of Unit. | Maximum Quantity or Number of Units. | Number of Repeats. |
101 | Mercuramide with Theophylline, Injection of | ........................... | 1 cc. amp..................... | 10 | .. |
| ........................... | 2 cc. amp..................... | 10 | .. | |
102 | Mersalyl, Injection of.................. | ........................... | 1 cc. amp..................... | 12 | .. |
|
| ........................... | 2 cc. amp..................... | 12 | .. |
103 | Methionine........................ | 50 G........................ | bottle....................... | 1 | .. |
104 | Methoin.......................... | 0.1 G........................ | tablet....................... | 100 | 1 |
105 | Methyl Atropine Nitrate................ | 1/200 gr. per cc................. | 1 cc. amp..................... | 6 | .. |
|
| 1/100 gr. per co................. | 1 cc. amp..................... | 6 | .. |
|
| 0. | ½ fl. oz. bottle................. | 1 | .. |
|
| 0.001 G...................... | tablet....................... | 20 | 1 |
106 | Morphine Hydrochloride............... | ¼ gr........................ | hypo. tab..................... | 20 | .. |
107 | Morphine Sulphate................... | ⅙ gr........................ | amp........................ | 6 | .. |
|
| ¼ gr........................ | amp........................ | 6 | .. |
|
| 1/3 gr....................... | amp........................ | 6 | .. |
|
| ½ gr........................ | amp........................ | 6 | .. |
|
| 1/12gr...................... | hypo. tab..................... | 20 | .. |
|
| 1/3 gr....................... | hypo. tab..................... | 20 | .. |
|
| ⅙gr........................ | hypo. tab..................... | 20 | .. |
|
| ¼ gr........................ | hypo. tab..................... | 20 | .. |
|
| 1/3 gr....................... | hypo. tab..................... | 20 | .. |
|
| ½ gr........................ | hypo. tab..................... | 20 | .. |
|
| 1 gr........................ | hypo. tab..................... | 12 | .. |
|
| ¼ gr. per cc.................... | 10 cc. vial.................... | 1 | .. |
|
| ½ gr. Per cc................... | 10 cc. vial.................... | 1 | .. |
First Schedule—continued.
Item Number. | Name or Formula. | Strength. | Form of Unit. | Maximum Quantity or Number of Units. | Number of Repeats. |
108 | Morphine with Atropine ............... | Morphine Sulphate 1/12 gr. | 1 hypo. tab.................... | 20 | .. |
|
| Atropine Sulphate 1/150 gr. |
| .. | |
|
| Morphine Sulphate ⅙ gr. | 1 hypo. tab.................... | 20 | .. |
|
| Atropine Sulphate 1/150 gr. |
|
| .. |
|
| Morphine Sulphate ⅙ gr |
|
| .. |
|
| Atropine Sulphate 1/200 gr. | 1 amp....................... | 6 | .. |
|
| Morphine Sulphate ⅙ gr. | 1 hypo. tab.................... | 20 | .. |
|
| Atropine Sulphate 1/180 gr. |
|
| .. |
|
| Morphine Sulphate ⅙ gr. | 1 hypo. tab.................... | 20 | .. |
|
| Atropine Sulphate 1/150 gr. per tab. or cc. | 1 cc. amp..................... | 6 | .. |
|
| 10 cc. vial.................... | 1 | .. | |
|
| Morphine Sulphate ⅙ gr. |
|
| .. |
|
| Atropine Sulphate 1/120 gr. | 1 amp....................... | 6 | .. |
|
| Morphine Sulphate ¼ gr. | 1 hypo. tab................... | 20 | .. |
|
| Atropine Sulphate 1/160 gr. per tab. or cc. | 1 cc. amp..................... | 6 | .. |
|
| 10 cc. vial.................... | 1 | .. | |
|
| Morphine Sulphate ¼ gr. | 1 hypo tab.................... |
| .. |
|
| Atropine Sulphate 1/120 gr. | I hypo. tab.................... | 20 | .. |
|
| Morphine Sulphate ¼ gr. |
| 20 | .. |
|
| Atropine Sulphate 1/100 gr. per tab. or amp. | hypo. tab..................... | 6 | .. |
|
| 1 amp....................... |
| .. | |
109 | Morphine with Hyoscine .............. | Morphine Sulphate ¼ gr. Hyoscine Hydrobromide 1/100 gr. | 1 cc. amp..................... | 6 | .. |
110 | Neoarsphenamine, Injection of........... | 0.15 G...................... | amp........................ | 2 | 1 |
|
| 0.3 G. ...................... | amp........................ | 2 | 1 |
|
| 0.45 G...................... | amp........................ | 2 | 1 |
|
| 0.6 G....................... | amp........................ | 2 | 1 |
|
| 0.75 G...................... | amp........................ | 2 | 1 |
|
| 0.9 G....................... | amp........................ | 2 | 1 |
First Schedule—continued.
Item Number. | Name or Formula. | Strength. | Form of Unit. | Maximum Quantity or Number of Units. | Number of Repeats. |
111 | Neo-Hepatex....................... | ........................... | 2 cc. amp..................... | 12 | 1 |
|
| ........................... | 10 cc. bottle.................. | 1 | 1 |
|
| ........................... | 25 cc. bottle.................. | 1 | 1 |
112 | Neostigmine Bromide................. | 15 mg....................... | tablet....................... | 100 | 1 |
113 | Neostigmine Methylsulphate, Injection of | 0.5 mg. per cc.................. | 1 cc. amp..................... | 6 | 3 |
| 2.5 mg. per cc.................. | 5 cc. vial.................... | 1 | 1 | |
114 | Nikethamide, Injection of............... | ........................... | 1.7 cc. amp................... | 5 | .. |
|
| ........................... | 2 cc. amp..................... | 6 | .. |
|
| ........................... | 5 cc. amp..................... | 3 | .. |
|
| ........................... | 5.5 cc. amp................... | 3 | .. |
115 | Nucleotides, Injection of................ | ........................... | 10 cc. amp.................... | 12 | .. |
116 | Ouabain, Injection of.................. | 0.25 mg...................... | amp........................ | 3 | .. |
|
| 0.5 mg....................... | amp........................ | 3 | .. |
117 | Oxophenarsine Hydrochloride, Injection of | 0.04 G....................... | amp........................ | 2 | 1 |
| 0.06 G....................... | amp........................ | 2 | 1 | |
118 | Oxytocin, Injection of................. | ........................... | 0.5 co. amp................... | 6 | .. |
|
| ........................... | 1 cc. amp..................... | 6 | .. |
119 | Pamaquin......................... | 0.01 G....................... | tablet....................... | 45 | .. |
|
| 0.018 G...................... | tablet....................... | 45 | .. |
|
| 0.036 G...................... | tablet....................... | 45 | .. |
First Schedule—continued.
Item Number. | Name or Formula. | Strength. | Form of Unit. | Maximum Quantity or Number of Units. | Number of Repeats. |
120 | Papaveretum ....................... | ⅙ gr. per cc................... | 1 cc. amp..................... | 6 | .. |
|
| 1/3 gr. per cc................... | 1 cc. amp..................... | 6 | .. |
|
| 1/3 gr....................... | hypo. tab..................... | 25 | .. |
|
| ⅙gr........................ | tablet....................... | 20 | .. |
121 | Papaverine Hydrochloride .............. | 1/3 gr. per cc................... | 1 cc. amp..................... | 6 | .. |
|
| 1½ gr. per 5 cc................. | 5 cc. amp..................... | 6 | .. |
|
| 2 gr. per 10 cc.................. | 10 cc. amp.................... | 6 | .. |
|
| 1/3 gr....................... | tablet ...................... | 25 | 1 |
|
| 1½ gr....................... | tablet ...................... | 25 | 1 |
122 | Paramethadione ..................... | 0.3 G........................ | capsule..................... | 100 | 2 |
123 | Parenamine ........................ | ........................... | 1,000 cc. bottle................ | 1 | .. |
124 | Penethamate Hydriodide ............... | 100,000 U.................... | vial........................ | 6 | .. |
|
| 500,000 U.................... | vial........................ | 3 | .. |
125 | Penicillin, Injection of ................. | 5,000 U...................... | amp........................ | 6 | .. |
|
| 15,000 U..................... | amp........................ | 6 | .. |
|
| 100,000 U.................... | amp........................ | 6 | .. |
|
| 200,000 U.................... | amp........................ | 6 | .. |
|
| 500,000 U.................... | amp........................ | 3 | .. |
|
| 1,000,000 U................... | amp........................ | 1 | .. |
|
| 1,500,000 U................... | amp........................ | 1 | .. |
126 | Penicillin, Procaine, Aqueous Suspension of | 300,000 U.................... | amp........................ | 3 | .. |
| 400,000 U.................... | vial ........................ | 3 | .. | |
|
| 600,000 U.................... | vial ........................ | 2 | .. |
|
| 900,000 U.................... | vial ........................ | 2 | .. |
|
| 1,000,000 U................... | vial ........................ | 1 | .. |
|
| 1,500,000 U................... | vial ........................ | 1 | .. |
First Schedule—continued.
Item Number. | Name or Formula. | Strength. | Form of Unit. | Maximum Quantity or Number of Units. | Number of Repeats. |
127 | Penicillin, Procaine (Crystalline), Injection of | 300,000 U.................... | amp........................ | 3 | .. |
|
| 400,000 U.................... | amp........................ | 3 | .. |
|
| 500,000 U.................... | amp........................ | 3 | .. |
|
| 600,000 U.................... | amp........................ | 2 | .. |
|
| 667,000 U.................... | amp........................ | 2 | .. |
|
| 900,000 U.................... | amp........................ | 2 | .. |
|
| 1,200,000 U................... | amp........................ | 1 | .. |
|
| 1,500,000 U................... | amp........................ | 1 | .. |
128 | Penicillin, Procaine, Oily Injection of | 300,000 U. per cc............... | 1 cc. amp..................... | 3 | .. |
|
| 600,000 U.................... | amp........................ | 2 | .. |
|
| 1,000,000 U................... | amp........................ | 1 | .. |
129 | Pernaemon Crudum................... | ........................... | 2 cc amp..................... | 12 | 1 |
|
| ........................... | 10 cc. vial.................... | 1 | 1 |
130 | Pernaemon Fort...................... | ........................... | 1 cc. amp..................... | 12 | 1 |
|
| ........................... | 5 cc. vial..................... | 1 | 1 |
131 | Pernexin .......................... | ........................... | 2 cc. amp..................... | 6 | 1 |
132 | Pertussis Vaccine (Phase 1) ............. | 1,000 M. per cc................. | 1 cc. amp..................... | 3 | 1 |
|
| 5,000 M. per cc................. | 1 cc. amp..................... | 3 | 1 |
|
| 5,000 M. per cc................. | 10 cc. vial.................... | 1 | .. |
|
| 10,000 M. per cc................ | 1 cc. amp..................... | 3 | 1 |
|
| 10,000 M. per cc................ | 10 cc. vial.................... | 1 | 1 |
|
| 20,000 M. per cc................ | 1 cc. amp..................... | 3 |
|
|
| 20,000 M. per cc................ | 5 cc. vial..................... | 1 | .. |
|
| 20,000 M. per cc................ | 10 cc. vial.................... | 1 | .. |
|
| 60,000 M. per 1.5 cc.............. | 1.5 cc. vial................... | 1 | .. |
|
| 50,000 M. per set ............... | set of 3 amps................... | 1 | .. |
First Schedule—continued.
Item Number. | Name or Formula. | Strength. | Form of Unit. | Maximum Quantity or Number of Units. | Number of Repeats. |
133 | Pethidine Hydrochloride ............... | 50 mg. per cc.................. | 1 cc. amp..................... | 6 | .. |
|
| 50 mg. per cc.................. | 2 cc. amp..................... | 6 | .. |
|
| 50 mg. per cc.................. | 10 cc. vial................... | 1 | .. |
|
| 50 mg. per cc.................. | 25 cc. bottle.................. | 1 | .. |
|
| 50 mg. per cc.................. | 50 cc. bottle.................. | 1 | .. |
|
| 25 mg....................... | tablet....................... | 25 | .. |
|
| 50 mg....................... | tablet....................... | 25 | .. |
134 | Pethidine Scopolamine | Pethidine Hydrochloride 100 mg. per amp. Scopolamine 0.43 mg. per amp | 2 cc. amp..................... | 6 | .. |
135 | Phemitone ........................ | ½ gr....................... | tablet....................... | 100 | 1 |
|
| 1 gr........................ | tablet....................... | 100 | 1 |
|
| 3 gr........................ | tablet....................... | 100 | 1 |
136 | Phenadoxone Hydrochloride............ | 10 mg. per cc.................. | 1 cc. amp..................... | 6 | .. |
|
| 10 mg....................... | tablet....................... | 25 | .. |
137 | Phenobarbitone Sodium, Injection of | 1½ gr. per cc.................. | 1 cc. amp..................... | 6 | .. |
|
| 3 gr. per cc................... | 1 cc. amp..................... | 6 | .. |
|
| 3 gr. per 1.5 cc................. | 1.5 cc. amp................... | 6 |
|
|
| 3 gr. per 2 cc.................. | 2 cc. amp..................... | 6 | .. |
|
| 3.1 gr. per 5 cc................. | 5 cc. amp..................... | 6 | .. |
138 | Phenylindanedione................... | 50 mg....................... | tablet ...................... | 50 | .. |
139 | Phenytoin Sodium................... | 0.03 G...................... | capsule..................... | 100 | 1 |
|
| 0.1 G....................... | capsule...................... | 100 | 1 |
|
| 0.1 G....................... | tablet....................... | 100 | 1 |
140 | Phthalylsulphacetamide................ | 0.5 G....................... | tablet....................... | 100 | .. |
First Schedule—continued.
Item Number. | Name or Formula. | Strength. | Form of Unit. | Maximum Quantity or Number of Units. | Number of Repeats. |
141 | Phthalylsulphathiazole................. | 0.5 G........................ | tablet....................... | 100 | .. |
142 | Physostigmine Sulphate................ | 1/100 gr...................... | hypo. tab..................... | 20 | .. |
143 | Picrotoxin, Injection of................ | 3 mg........................ | amp........................ | 6 | .. |
|
| 5 mg........................ | amp........................ | 6 | .. |
|
| 0.3%....................... | 20 cc. bottle.................. | 1 | .. |
144 | Pitressin Tannate in Oil, Injection of | ........................... | 1 cc. amp..................... | 12 | 1 |
145 | Pituitary (Posterior Lobe), Injection of | ........................... | 0.5 cc. amp................... | 6 | .. |
|
| ........................... | 1 cc. amp..................... | 6 | .. |
146 | Primidone......................... | 0.25 G....................... | tablet....................... | 100 | 2 |
147 | Procaine Hydrochloride in Normal Saline for Injection | 0.1% ....................... | 1 litre bottle.................. | 2 | 1 |
148 | Procyclidine Hydrochloride............. | 5 mg........................ | tablet....................... | 100 | 1 |
149 | Proguanil Hydrochloride............... | 0.1 G........................ | tablet....................... | 100 | 1 |
150 | Promethazine Hydrochloride, Injection of | 2.5%....................... | 2 cc. amp..................... | 10 | .. |
151 | Protamine Sulphate................... | 1%......................... | 5 mil. amp.................... | 6 | .. |
|
| 1%......................... | 10 cc. amp.................... | 3 | .. |
152 | Protolex.......................... | ........................... | 2 cc. amp..................... | 12 | 1 |
|
| ........................... | 10 cc. amp.................... | 1 | 1 |
First Schedule—continued.
Item Number. | Name or Formula. | Strength. | Form of Unit. | Maximum Quantity or Number of Units. | Number of Repeats. |
153 | Pyridoxine Hydrochloride, Injection of | 50 mg. per cc.................. | 1 cc. amp..................... | 6 | 1 |
| 50 mg. per 2 cc................. | 2 cc. amp..................... | 6 | 1 | |
|
| 50 mg. per cc.................. | 5 cc. vial..................... | 1 | 1 |
|
| 50 mg. per cc.................. | 10 cc. vial.................... | 1 | .. |
154 | Quinidine Sulphate................... | 3 gr........................ | tablet....................... | 100 | 1 |
155 | Reticulogen........................ | ........................... | 0.5 cc. amp.................... | 6 | 1 |
|
| ........................... | 5 cc. amp..................... | 1 | 1 |
156 | Ringer’s Solution for Injection........... | ........................... | 1 litre bottle................... | 4 | 1 |
157 | Rondase.......................... | 3 mg........................ | amp........................ | 6 | 1 |
158 | Sodium Aurothiomalate, Aqueous Injection of | 0.001 G...................... | amp........................ | 1 | 3 |
| 0.002 G...................... | amp........................ | 1 | 3 | |
|
| 0.005 G...................... | amp........................ | 1 | 3 |
|
| 0.01 G....................... | amp........................ | 1 | 3 |
|
| 0.02 G....................... | amp........................ | 1 | 3 |
|
| 0.05 G....................... | amp........................ | 6 | 1 |
|
| 0.1 G........................ | amp........................ | 6 | 1 |
|
| 0.2G........................ | amp........................ | 1 | 3 |
159 | Sodium Aurothiomalate, Oily Injection of | 0.01 G....................... | amp........................ | 1 | 3 |
| 0.02 G....................... | amp........................ | 1 | 3 | |
|
| 0.05 G....................... | amp........................ | 6 | 1 |
160 | Sodium Chloride Hypertonic Solution for Injection | 3%......................... | 1 litre bottle................... | 2 | 1 |
| 5%......................... | 1 litre bottle................... | 2 | 1 |
First Schedule—continued.
Item Number. | Name or Formula. | Strength. | Form of Unit. | Maximum Quantity or Number of Units. | Number of Repeats. |
161 | Sodium Chloride Physiological Solution for Injection | ........................... | 2 cc. amp..................... | 6 | 1 |
|
| ........................... | 5 cc. amp..................... | 6 | 1 |
|
| ........................... | 10 cc. amp.................... | 6 | 1 |
|
| ........................... | 20 cc. amp.................... | 6 | 1 |
|
| ........................... | 50 cc. amp.................... | 3 | 1 |
|
| ........................... | 1 litre bottle .................. | 2 | 1 |
162 | Sodium Chloride Physiological Solution (with Dextrose) for Injection | 5% Dextrose.................. | 1 litre bottle .................. | 2 | 1 |
|
| 10% Dextrose.................. | 1 litre bottle................... | 2 | 1 |
|
| 20% Dextrose.................. | 1 litre bottle .................. | 2 | 1 |
|
| 25% Dextrose.................. | 1 litre bottle .................. | 2 | 1 |
163 | Sodium Sulphate Solution for Injection | 4.28%....................... | 1 litre bottle .................. | 2 | 1 |
164 | Solapsone......................... | 7 gr....................... | tablet ....................... | 200 | .. |
165 | Succinylsulphathiazole................. | 0.5 G........................ | tablet ....................... | 100 | .. |
166 | Sulphacetamide...................... | 0.5 G........................ | tablet ....................... | 50 | .. |
167 | Sulphadiazine....................... | 0.3 G ....................... | tablet ....................... | 50 | .. |
|
| 0.5 G........................ | tablet ....................... | 50 | .. |
168 | Sulphadimidine...................... | 0.25 G....................... | tablet ....................... | 50 | .. |
|
| 0.5 G........................ | tablet ....................... | 50 | .. |
First Schedule—continued.
Item Number. | Name or Formula. | Strength. | Form of Unit. | Maximum Quantity or Number of Units. | Number of Repeats. |
169 | Sulphafurazole...................... | 0.5 G....................... | tablet....................... | 50 | .. |
170 | Sulphaguanidine.................... | 0.5 G....................... | tablet....................... | 100 | .. |
171 | Sulphamerazine..................... | 0.5 G....................... | tablet....................... | 50 | .. |
172 | Sulphamethizole.................... | 0.1 G....................... | tablet....................... | 30 | .. |
173 | Sulphamethizole.................... | 0.5G........................ | tablet....................... | 50 | .. |
174 | Sulpharsphenamine, Injection of.......... | 0.16........................ | amp........................ | 2 | 1 |
|
| 0.15 G...................... | amp........................ | 2 | 1 |
|
| 0.3 G....................... | amp........................ | 2 | 1 |
|
| 0.45 G...................... | amp........................ | 2 | 1 |
|
| 0.6 G....................... | amp........................ | 2 | 1 |
|
| 0.75 G...................... | amp........................ | 2 | 1 |
|
| 0.9 G....................... | amp........................ | 2 | 1 |
175 | Sulphathiazole...................... | 0.3 G....................... | capsule...................... | 50 | .. |
|
| 0.5 G....................... | tablet....................... | 50 | .. |
176 | Sulphonamides, Mixed, (A)—Two Sulphonamides | 0.25 G...................... | tablet....................... | 50 | .. |
| 0.3 G....................... | tablet....................... | 50 | .. | |
|
| 0.5 G....................... | tablet....................... | 50 | .. |
First Schedule—continued.
Item Number. | Name or Formula. | Strength. | Form of Unit. | Maximum Quantity or Number of Units. | Number of Repeats. |
177 | Sulphonamides, Mixed, (B)—Three Sulphonamides | 0.25 G...................... | tablet....................... | 50 | .. |
| 0.3 G....................... | tablet....................... | 50 | .. | |
|
| 0.33 G...................... | tablet....................... | 50 | .. |
|
| 0.5 G....................... | tablet....................... | 50 | .. |
178 | Sulphonamides, Mixed, (C)—Four Sulphonamides | 0.3 G....................... | tablet....................... | 50 | .. |
| 0.5 G....................... | tablet....................... | 50 | .. | |
179 | Suprarenal Cortex Extract, Injection of | 200γ per cc................... | 10 cc. bottle.................. | 3 | 1 |
| .......................... | 10 cc. vial.................... | 3 | 1 | |
180 | T.A.B. Vaccine (Antityphoid-paratyphoid) | 1 cc. containing— | 1 cc. amp..................... | 3 | .. |
| 1,000 M. Typhosus | 10 cc. vial.................... | 1 | .. | |
|
| 500 M. Para-typhosus A |
|
|
|
|
| 500 M. Para-typhosus B |
|
|
|
181 | Tetanus Antitoxin.................... | 500 I.U...................... | amp........................ | 6 | 1 |
|
| 1,000 I.U..................... | amp........................ | 6 | 1 |
|
| 1,500 I.U..................... | amp........................ | 6 | 1 |
|
| 5,000 I.U..................... | amp........................ | 6 | 1 |
|
| 10,000 I.U.................... | amp........................ | 6 | 1 |
182 | Tetanus Toxoid (Formalinized)........... | .......................... | 1 cc. amp..................... | 3 | .. |
183 | Theophylline with Ethylenediamine | 0.366 G. per 10 mil.............. | 10 mil. amp................... | 6 | .. |
|
| 0.732 G. per 2 mil............... | 2 mil. amp.................... | 6 | .. |
|
| 0.48 G. per 2 mil................ | 2 mil. I.M. amp................. | 6 | .. |
|
| 0.5 G. per 2 mil................ | 2 mil. I.M. amp................. | 6 | .. |
|
| 0.24 G. per 10 mil............... | 10 mil. I.V. amp................ | 6 | .. |
|
| 0.25 G. per 10 mil............... | 10 mil. I.V. amp................ | 6 | .. |
|
| 1½ gr....................... | tablet....................... | 100 | 1 |
|
| 2.34 gr...................... | tablet ...................... | 100 | 1 |
First Schedule—continued.
Item Number. | Name or Formula | Strength. | Form of Unit. | Maximum Quantity or Number of Units. | Number of Repeats. |
184 | Thiacetazone....................... | 25 mg....................... | tablet....................... | 100 | .. |
|
| 50 mg....................... | tablet....................... | 50 | .. |
185 | Thiouracil, Methyl................... | 0.05 G....................... | tablet....................... | 100 | 1 |
|
| 0.1 G........................ | tablet....................... | 100 | 1 |
|
| 0.2 G........................ | tablet....................... | 100 | 1 |
186 | Thiouracil, Propyl.................... | 25 mg....................... | tablet....................... | 100 | 1 |
|
| 50 mg....................... | tablet....................... | 100 | 1 |
187 | Thyroid B.P........................ | 1/32 gr....................... | tablet....................... | 100 | 3 |
|
| 1/16 gr...................... | tablet....................... | 100 | 3 |
|
| 1/10 gr...................... | tablet....................... | 100 | 3 |
|
| ⅛ gr......................... | tablet....................... | 100 | 3 |
|
| ¼ gr........................ | tablet....................... | 100 | 3 |
|
| ½ gr........................ | tablet....................... | 100 | 3 |
|
| 1 gr........................ | tablet....................... | 100 | 3 |
|
| 1½ gr........................ | tablet....................... | 100 | 3 |
|
| 2 gr........................ | tablet....................... | 100 | 3 |
|
| 2½ gr........................ | tablet....................... | 100 | 3 |
|
| 5 gr........................ | tablet....................... | 100 | 3 |
188 | Tiger Snake Anti-venene............... | 1,500 U...................... | amp........................ | 4 | 1 |
189 | Triethanolamine Trinitrate.............. | 1 mg........................ | tablet....................... | 50 | 1 |
190 | Troxidone......................... | 0.3 G........................ | capsule..................... | 100 | 1 |
|
| 0.15 G....................... | tablet....................... | 100 | 1 |
First Schedule—continued.
Item Number. | Name or Formula. | Strength. | Form of Unit. | Maximum Quantity or Number of Units. | Number of Repeats. |
191 | Vasopressin, Injection of .......... | ........................ | 0.5 cc. amp................. | 6 | .. |
|
| ........................ | 1 cc. amp.................. | 6 | .. |
192 | Vitamin K, Aqueous Injection of .... | 2.5 mg. per 0.5 cc............. | 0.5 cc, amp................. | 6 | 1 |
|
| 5 mg. per cc. ............... | 1 cc. amp.................. | 6 | 1 |
|
| 10 mg. per cc................ | 1 cc. amp.................. | 6 | 1 |
|
| 75 mg. per cc................ | 1 cc. amp.................. | 6 | 1 |
193 | Vitamin K, Oily Injection of ....... | 5 mg. per cc................ | 1 cc. amp.................. | 6 | 1 |
|
| 10 mg. per cc................ | 1 cc. amp.................. | 6 | 1 |
194 | Vitamin K (Oral) ............... | 1 mg..................... | capsule ................... | 100 | 1 |
|
| 1 mg..................... | tablet .................... | 100 | 1 |
|
| 4 mg..................... | capsule ................... | 100 | 1 |
|
| 4.8 mg. ................... | tablet .................... | 100 | 1 |
|
| 5 mg..................... | tablet.................... | 100 | 1 |
|
| 10 mg.................... | tablet .................... | 100 | 1 |
195 | Water for Injection .............. | ......................... | 2 cc. amp.................. | 6 | 1 |
|
| ........................ | 5 cc. amp. ................. | 12 | 1 |
|
| ........................ | 10 cc. amp. ................ | 12 | 1 |
196 | Wydase ..................... | 150 U..................... | amp. .................... | 5 | 1 |
SECOND SCHEDULE.
Reg. 8.
Drugs and Medicinal Preparations that may be Prescribed for Supply, Supplied and Received as General Pharmaceutical Benefits Only for the Treatment of a Disease or Purpose.
Item Number. | Name or Formula. | Strength. | Form of Unit. | Maximum Quantity or Number of Units. | Number of Repeats. | Disease or Purpose. |
1 | Aureomycin .............. | 50 mg. .......... | capsule .......... | 25 | .. | Acute amoebic dysentery |
|
| 100 mg. ......... | capsule .......... | 25 | .. | Acute and sub-acute bacterial endocarditis-streptococcus faecalis |
|
| 250 mg. .......... | capsule .......... | 16 | .. | |
|
| 100 mg. ......... | vial ............ | 6 | .. | Staphylococcal infections that do not respond to penicillin |
|
|
|
|
|
| Pneumonia that has not responded to penicillin or to sulphonamides Psittacosis |
|
|
|
|
|
| |
|
|
|
|
|
| Urinary tract infections due to streptococcus faecalis |
2 | Calcium Para-aminosalicylate | 1.5G. ........... | cachet .......... | 200 | 1 | Tuberculosis |
| 2.0 G. ........... | cachet .......... | 200 | 1 |
| |
|
| 5 gr. ............ | tablet ........... | 200 | 1 |
|
|
| 7½ gr. .......... | tablet ........... | 200 | 1 |
|
|
| ............... | 100 G. tin ........ | 1 | 1 |
|
|
| ................ | 400 G. tin ........ | 1 | 1 |
|
3 | Caramiphen Hydrochloride | 0.05 G........... | tablet ........... | 100 | 1 | Parkinsonism |
4 | Chloramphenicol ........... | 0.125 G. ......... | capsule .......... | 16 | .. | Typhoid fever |
|
| 0.25 G. .......... | capsule .......... | 16 | .. | Brucellosis |
|
|
|
|
|
| Typhus and other rickettsial diseases |
|
|
|
|
|
| Influenzal meningitis |
|
|
|
|
|
| Granuloma inguinale |
|
|
|
|
|
| Lymphogranuloma venereum |
|
|
|
|
|
| Whooping cough (haemophilus pertussis) Infections due to haemophilus influenza Acute laryngo-tracheo-bronchitis |
|
|
|
|
|
|
|
Second Schedule—continued.
Item Number. | Name or Formula. | Strength. | Form of Unit. | Maximum Quantity or Number of Units. | Number | Disease or Purpose. |
4— | Chloramphenicol—continued. |
|
|
|
| Salmonella infections |
contd. |
|
|
|
|
| Severe gastro-enteritis in children Staphylococcal infections that do not respond to either penicillin or aureomycin |
|
|
|
|
|
| Urinary tract infections due to gram negative bacilli that do not respond to sulphonamides |
|
|
|
|
|
| Meningitis due to bacterium coli if other forms of treatment are unsuccessful |
5 | Chloramphenicol Palmitate | 0.125 G. per 4 cc. | 60 cc. bottle ...... | 1 | .. | Any disease or purpose specified in this column in relation to chloramphenicol |
6 | Cortisone Acetate ........... | 25 mg. ......... | tablet .......... | 40 | 1 | Acute rheumatic carditis |
|
| 25 mg. per cc. .... | 20 cc. vial ....... | 1 | .. | Addison’s disease |
|
| 50 mg. per cc. .... | 10 cc. vial ....... | 1 | .. | Total adrenalectomy Status asthmaticus |
7 | Deoxycortone Acetate, Aqueous Injection of | 5 mg. .......... | amp. ........... | 4 | .. | Addison’s disease |
| 50 mg. ......... | amp. ........... | 1 | .. |
| |
8 | Deoxycortone Acetate, Aqueous Suspension of | 25 mg. .......... | amp. ........... | 1 | .. | Addison’s disease |
| 50 mg. ......... | amp. ........... | 1 | .. |
| |
9 | Deoxycortone Acetate, Oily Injection of | 2 mg. .......... | amp. ........... | 4 | .. | Addison’s disease |
| 5 mg. .......... | amp. ........... | 4 | .. |
| |
|
| 10 mg. .......... | amp. ........... | 4 | .. |
|
|
| 50 mg. .......... | implant ......... | 1 | .. |
|
|
| 100 mg. ........ | implant ......... | 1 | .. |
|
|
| 5 mg. per cc. ..... | 5 cc. vial ........ | 1 | .. |
|
|
| 10 mg. per cc...... | 10 cc. vial ....... | 1 | .. |
|
Second Schedule—continued.
Item Number. | Name or Formula. | Strength. | Form of Unit. | Maximum Quantity or Number of Units. | Number of Repeats. | Disease or Purpose. |
10 | Dienoestrol ............... | 5 mg............ | tablet ........... | 100 | 1 | Carcinoma of the prostate |
|
| 10 mg........... | tablet ........... | 100 | 1 | Mammary carcinoma |
11 | Dihydrostreptomycin ......... | 1 G............. | vial ............ | 5 | 3 | Any disease or purpose specified in this column in relation to streptomycin, but only if the person being treated for that disease or purpose is allergic to streptomycin |
12 | Folic Acid ................ | 15 mg. per cc....... | 1 cc. amp ........ | 12 | .. | Sprue or the sprue-like syndrome |
|
| 5 mg............ | tablet ........... | 100 | 1 |
|
13 | Isoniazid ................. | 50 mg. ........... | tablet ............ | 100 | 1 | Tuberculosis |
|
| 100 mg. ......... | tablet ........... | 100 | 1 |
|
14 | Pancreatin ................ | 5 gr. ............ | tablet ........... | 100 | .. | Fibrocystic disease of the pancreas |
15 | Para-Aminosalicylic Acid ..... | 0.3 G. ........... | tablet ........... | 200 | 1 | Tuberculosis |
|
| 0.5 G. ........... | tablet ........... | 200 | 1 |
|
16 | Phenindamine Tartrate ........ | 25 mg. .......... | tablet ........... | 100 | 1 | Parkinsonism |
17 | Progesterone, Injection of...... | 5 mg. ........... | amp............. | 6 | .. | Threatened abortion |
|
| 10 mg. .......... | amp. ............ | 6 | .. |
|
|
| 20 mg. .......... | I.V. amp.......... | 3 | .. |
|
18 | Quinine Bisulphate .......... | 5 gr.............. | tablet ............ | 100 | 1 | Malaria |
Second Schedule—continued.
Item Number. | Name or Formula. | Strength. | Form of Unit. | Maximum Quantity or Number of Units. | Number of Repeats. | Disease or Purpose. |
19 | Quinine Dihydrochloride ...... | 3 gr. per cc......... | 1 cc. amp......... | 6 | 1 | Malaria |
|
| 6¼ gr. per cc....... | 1 cc. amp......... | 6 | 1 |
|
|
| 9¼ gr. per 2 cc...... | 2 cc. amp......... | 6 | 1 |
|
|
| 15½ gr. per 2 cc..... | 2 cc. amp......... | 6 | 1 |
|
|
| 5 gr............. | capsule ......... | 100 | 1 |
|
|
| 5 gr............. | tablet ........... | 100 | 1 |
|
20 | Quinine Hydrochloride ....... | 5 gr............. | tablet ........... | 100 | 1 | Malaria |
21 | Quinine Sulphate ........... | 5 gr............. | tablet ........... | 100 | 1 | Malaria |
22 | Sodium Para-Aminosalicylate | 1.5G............. | cachet .......... | 200 | 1 | Tuberculosis |
|
| 2.0.G............ | cachet .......... | 200 | 1 |
|
|
| 0.5 G ........... | capsule ......... | 200 | 1 |
|
|
| 5 gr............. | tablet ........... | 200 | 1 |
|
|
| 7½ gr............ | tablet ........... | 200 | 1 |
|
|
| 20% ............ | 10 cc. vial ....... | 6 | .. |
|
23 | Stilboestrol ............... | 1 mg............. | amp............ | 6 | .. | Carcinoma of the prostate |
|
| 5 mg............. | amp............ | 6 | .. | Mammary carcinoma |
|
| 1 mg. ........... | tablet ........... | 100 | 1 |
|
|
| 5 mg............. | tablet ........... | 100 | 1 |
|
|
| 10 mg............ | tablet ........... | 100 | 1 |
|
24 | Streptomycin .............. | 1 G.............. | vial ............ | 5 | 3 | Infections due to haemophilus influenza Chancroid |
|
|
|
|
|
| Pneumonia due to bacillus Friedlander |
|
|
|
|
|
| Acute tuberculosis |
|
|
|
|
|
| Acute exacerbations in chronic tuberculosis Salmonella infections |
Second Schedule—continued.
Item Number. | Name or Formula. | Strength. | Form of Unit. | Maximum Quantity or Number of Units. | Number of Repeats. | Disease or Purpose. |
24— contd. | Streptomycin—continued. |
|
|
|
| Bacillary dysentery not responding to sulphonamides |
|
|
|
|
|
| Surgical conditions of the bowel and of the thoracic organs |
|
|
|
|
|
| Tularaemia |
|
|
|
|
|
| Infections due to pseudomonas pyocyaneus |
25 | Streptomycin Sulphate Solution for Injection | 250,000 U. per mil. | 4 mil. vial ........ | 5 | 3 | Any disease or purpose specified in this column in relation to streptomycin |
26 | Terramycin ............... | 50 mg.......... | capsule .......... | 25 | .. | Acute amoebic dysentery |
|
| 100 mg......... | capsule .......... | 25 | .. | Acute and sub-acute bacterial endocarditis-streptococcus faecalis |
|
| 250 mg......... | capsule .......... | 16 | .. | |
|
| 50 mg.......... | tablet ........... | 25 | .. | Staphylococcal infections that do not respond to penicillin |
|
| 100 mg. ........ | tablet ........... | 25 | .. | |
|
| 250 mg......... | tablet ........... | 16 | .. | Pneumonia that has not responded to penicillin or to sulphonamides |
|
| 100 mg......... | vial ............ | 6 | .. | |
|
| 250 mg. per 10 cc.. | 10 cc. vial ........ | 6 | .. | Psittacosis |
|
|
|
|
|
| Urinary tract infections due to streptococcus faecalis |
27 | Terramycin Oral Suspension | 0.25 G. per 5 cc.... | 1 fl. oz. bottle ..... | 1 | .. | Any disease or purpose specified in this column in relation to terramycin |
28 | Testosterone .............. | 100 mg......... | implant .......... | 1 | .. | Mammary carcinoma |
|
| 150 mg......... | implant .......... | 1 | .. | Castration |
|
| 200 mg......... | implant .......... | 1 | .. |
|
29 | Testosterone, Methyl ......... | 25 mg.......... | tablet ........... | 25 | 1 | Mammary carcinoma |
|
| 50 mg.......... | tablet ........... | 25 | 1 | Castration |
Second Schedule—continued.
Item Number. | Name or Formula. | Strength. | Form of Unit. | Maximum Quantity or Number of Units. | Number of Repeats. | Disease or Purpose. |
30 | Testosterone Oenanthate, Injection of | 250 mg. per cc..... | 1 cc. amp......... | 1 | .. | Mammary carcinoma Castration |
31 | Testosterone Phenyl Propionate, Injection of | 50 mg. per cc...... | 1 cc. amp......... | 3 | .. | Mammary carcinoma Castration |
| 50 mg. per cc...... | 5 cc. vial ......... | 1 | .. | ||
32 | Testosterone Propionate, Injection of | 25 mg. per cc...... | 1 cc. amp......... | 12 | .. | Mammary carcinoma Castration |
| 50 mg. per cc...... | 1 cc. amp......... | 12 | .. | ||
|
| 50 mg. per cc...... | 10 cc. vial........ | 1 | .. |
|
|
| 100 mg. per 2 mil... | 2 mil. amp........ | 1 | .. |
|
|
| 100 mg......... | implant ......... | 1 | .. |
|
33 | Tetracycline .............. | 50 mg. ......... | capsule .......... | 25 | .. | Any disease or purpose specified in this column in relation to aureomycin |
|
| 100 mg.......... | capsule .......... | 25 | .. | |
|
| 250 mg. ........ | capsule .......... | 16 | .. |
|
|
| 50 mg. ......... | tablet ........... | 25 | .. |
|
|
| 100 mg.......... | tablet ........... | 25 | .. |
|
|
| 250 mg.......... | tablet ........... | 16 | .. |
|
|
| 100 mg. ........ | vial ............. | 6 | .. |
|
34 | Vitamin B12, Injection of ...... | 10γ per cc....... | 1 cc. amp......... | 12 | 1 | Established megalocytic anaemias |
|
| 15γ per cc........ | 1 cc. amp......... | 12 | 1 |
|
|
| 20γ per cc........ | 1 cc. amp......... | 12 | 1 |
|
|
| 50γ per cc........ | 1 cc. amp......... | 6 | 1 |
|
|
| 100γ per cc....... | 1 cc. amp......... | 1 | 1 |
|
|
| 100γ per cc....... | 10 cc. vial ........ | 1 | .. |
|
|
| 200γ per cc....... | 1 cc. amp......... | 1 | .. |
|
|
| l,000γ per cc...... | 1 cc. amp......... | 1 | .. |
|
|
| l,000γ per cc...... | 10 cc. vial ........ | 1 | .. |
|
THIRD SCHEDULE.
Reg. 10.
Pensioner Benefits Additional to those Covered by Monograph in the British Pharmacopoeia.
Item No. | Name or Formula of Drug or Medicinal Preparation. |
1 | Acetonum B.P.C. |
2 | Acetum Scillae |
3 | Acidum Hydrocyanicum Dilution B.P.C. |
4 | Acidum Sulphuricum Dilutum B.P.C. |
5 | Acidum Hypophosphorosum Dilutum |
6 | Acriflavina |
7 | Adeps |
8 | Adeps Benzoinatus |
9 | Aethylenum |
10 | Agar |
11 | Amidopyrina |
12 | Ammonii Bromidum B.P.C. |
13 | Aqua (Potable Water) |
14 | Aqua Anisi B.P.C. |
15 | Aqua Chlorbutolis A.P.E. |
16 | Argentoproteinum Mite B.P.C. |
17 | Balsamum Peruvianum |
18 | Betanaphthol |
19 | Caffeina Citrata B.P.C. |
20 | Caffeina et Sodii Benzoas |
21 | Calcii Mandelas |
22 | Capsulae Sodii Pentobarbitoni |
23 | Cera Flava |
24 | Chiniofonum |
25 | Chromii Trioxidum |
26 | Codeina |
27 | Cremor Penicillini Sterilisatus |
28 | Ephedrinae Sulphas B.P.C. |
29 | Extractum Colchici Siccum |
30 | Extractum Colocynthidis Compositum |
31 | Extractum Ergotae Liquidum |
32 | Extractum Fellis Bovini |
33 | Extractum Glycyrrhizae |
34 | Extractum Hepatis Liquidum |
35 | Extractum Krameriae Siccum |
36 | Extractum Senegae Liquidum |
37 | Ferri Carbonas Saccharatus |
38 | Glycerinum Acidi Borici |
39 | Glycerinum Boracis |
40 | Hexoestrol |
41 | Hydrargyrum cum Creta |
42 | Infusum Aurantii |
43 | Infusum Aurantii Concentratum |
44 | Infusum Buchu B.P.C. |
45 | Infusum Calumbae |
46 | Infusum Calumbae Concentratum |
47 | Infusum Calumbae Recens |
48 | Infusum Caryophylli |
49 | Infusum Caryophylli Concentratum |
50 | Infusum Senegae |
51 | Infusum Senegae Concentratum |
52 | Infusum Sennae |
53 | Infusum Sennae Concentratum |
54 | Injectio Caffeinae et Sodii Benzoatis |
55 | Injectio Oestradiolis Dipropionatis |
56 | Injectio Penicillini Oleosa |
57 | Injectio Physostigminae Salicylatis |
58 | Injectio Pituitarii Posterioris |
Third Schedule—continued.
Item No. | Name or Formula of Drug or Medicinal Preparation. |
59 | Injectio Procainae et Adrenalinae Mitis |
60 | Injectio Sodii Citratis Anticoagulans |
61 | Injectio Sodii Citratis cum Dextroso |
62 | Injectio Strychninae Hydrochloridi |
63 | Injectio Sulphadiazinae Sodii |
64 | Iodoformum |
65 | Ipomoeae Resina |
66 | Laevulosum |
67 | Linimentum Aconiti |
68 | Linimentum Belladonnae |
69 | Liquor Ammoniae Aromaticus B.P.C. |
70 | Liquor Glycerylis Trinitratis B.P.C. |
71 | Liquor Magnesii Bicarbonatis |
72 | Magenta B.P.C. |
73 | Magnesii Phosphas B.P.C. |
74 | Mel Depuratum |
75 | Mistura Aluminii Hydroxidi A.P.F. |
76 | Mistura Sennae Composita |
77 | Oestradiolis Dipropionas |
78 | Oestronum |
79 | Oculentum Cocainae |
80 | Oculentum Physostigminae |
81 | Oleum Cajuputi |
82 | Oleum Cari |
83 | Oleum Citronellae B.P.C. |
84 | Oleum Cocois B.P.C. |
85 | Oleum Pini B.P.C. |
86 | Oxymel Scillae |
87 | Pelletierinae Tannas |
88 | Phenazonum |
89 | Pilula Aloes |
90 | Pilula Aloes et Nux Vomica B.P.C. |
91 | Pilula Colocynthidis et Hyoscyami |
92 | Pilula Digitalis Composita B.P.C. |
93 | Pilula Ferri Carbonatis |
94 | Pilula Hydrargyri |
95 | Pilula Phenolphthalein Composita B.P.C. |
96 | Pilula Rhei Composita |
97 | Pilula Sodii Oleatis Composita A.P.F. |
98 | Pix Carbonis B.P.C. |
99 | Potassii Acetas |
100 | Potassii Chloras |
101 | Quininae et Aethylis Carbonas |
102 | Sapo Animalis |
103 | Sapo Durus |
104 | Sodii Carbonas Exsiccatus |
105 | Sodii Nitris |
106 | Sodii Phosphas Exsiccatus |
107 | Sodii Sulphas Exsiccatus |
108 | Spiritus Aetheris Nitrosi |
109 | Spiritus Cajuputi |
110 | Spiritus Camphorae |
111 | Strychnina B.P.C. |
112 | Sulphacetamidum |
113 | Sulphadiazina Sodium |
114 | Sulphonal |
115 | Suppositoria Acidi Tannici |
116 | Suppositoria Belladonnae |
117 | Suppositoria Bismuthi Subgallatis |
118 | Suppositoria Cocainae |
119 | Suppositoria Hamamelidis et Zinci Oxidi |
120 | Suppositoria Iodoformi |
Third Schedule—continued.
Item No. | Name or Formula of Drug or Medicinal Preparation. |
121 | Suppositoria Morphinae |
122 | Suppositoria Phenolis |
123 | Syrupus Ferri Phosphatis Compositus |
124 | Syrupus Glucosi Liquidi |
125 | Syrupus Glycerophosphatum Compositus A.P.F. |
126 | Syrupus Limonis Neutralis A.P.F. |
127 | Syrupus Pruni Serotinae |
128 | Syrupus Ruber A.P.F. |
129 | Syrupus Scillae |
130 | Syrupus Theriacae Aureae A.P.F. |
131 | Tabellae Acidi Acetylsalicylic Co. B.P.C. |
132 | Tabellae Aminophyllinae et Phenobarbitonum B.P.C. |
133 | Tabellae Aminophyllinae gr. 1½ cum Phenobarbitoni gr. ½ |
134 | Tabellae Ammonii Chloridi B.P.C. |
135 | Tabellae Calcii Gluconatis B.P.C. |
136 | Tabellae Ephedrinae gr. ½ cum Phenobarbitoni gr. ½ |
137 | Tabellae Hexoestrolis |
138 | Tabellae Hydrargyri cum Creta |
139 | Tabellae Oestroni |
140 | Tabellae Phenazoni |
141 | Tabellae Potassii Chloratis |
142 | Tabellae Sodii Pentobarbitoni |
143 | Tabellae Sodii Salicylatis |
144 | Tabellae Theobrominae et Phenobarbitoni B.P.C. |
145 | Tabellae Theobrominae et Sodii Salicylatis B.P.C. |
146 | Tabellae Thiouracili |
147 | Talcum Purificatum B.P.C. |
148 | Theophyllina et Sodii Acetas |
149 | Thiouracilum |
150 | Tinctura Calumbae |
151 | Tinctura Capsici |
152 | Tinctura Catechu |
153 | Tinctura Cocci |
154 | Tinctura Gelsemii B.P.C. |
155 | Tinctura Lobeliae Aetherae B.P.C. |
156 | Tinctura Myrrhae |
157 | Tinctura Persionis A.P.F. |
158 | Tinctura Quassiae |
159 | Tinctura Scillae |
160 | Tinctura Senegae |
161 | Tinctura Strophanthi |
162 | Tinctura Tolutana |
163 | Tinctura Valerianae ammoniata |
164 | Triethanolamina B.P.C. |
165 | Unguentum Capsici |
166 | Unguentum Gallae cum Opio B.P.C. |
167 | Unguentum Hydrargyri Compositum |
168 | Unguentum Hydrargyri Subchloridi |
169 | Unguentum Phenolis |
170 | Unguentum Zinci Oleatis |
171 | Unguentum Zinci Oxidi Aquosum |
172 | Xylenum B.P.C. |
Fourth Schedule.
6. The Fourth Schedule to the National Health (Pharmaceutical Benefits) Regulations is amended by omitting the words and figures—
“Tablets— |
|
Tablets of phenobarbitone ........................................ | 100 |
Tablets of phenobarbitone sodium ................................... | 100 |
Other tablets ................................................. | 25” |
and inserting in their stead the words and figures— |
|
“Tablets— |
|
Tablets of aminophylline with phenobarbitone ........................... | 100 |
Tablets of calcium gluconate ....................................... | 100 |
Tablets of phenobarbitone ........................................ | 100 |
Tablets of phenobarbitone sodium ................................... | 100 |
Tablets of theobromine with phenobarbitone ............................ | 100 |
Other tablets ................................................. | 25” |
Fifth Schedule.
7. The Fifth Schedule to the National Health (Pharmaceutical Benefits) Regulations is amended by omitting the figures and words—
“126 | Penicillin, Procaine, Aqueous Suspension of | Vial .. | 12” |
and inserting in their stead the figures and words—
“126 | Penicillin, Procaine, Aqueous Suspension of | Ampoule or Vial | 12”. |
By Authority: L. F. Johnston, Commonwealth Government Printer, Canberra.